Silver Book Fact

The average direct cost of glaucoma treatment ranges from $623 per year for patients with early-stage glaucoma, to $2,511 per year for end-stage patients. Medication costs make up the largest proportion of the total direct costs for all stages of the disease.

Lee, Paul P., John G. Walt, John L. Doyle, Sameer V. Kotak, Stacy J. Evans, Donald L. Budenz, Philip P. Chen, Anne L. Coleman, Robert M. Feldman, Henry D. Jampel, L. Jay Katz, Richard P. Mills, Jonathan S. Myers, Robert J. Noecker, et al. A Multicenter, Retrospective Pilot Study of Resource Use and Costs Associated with Severity of Disease in Glaucoma. Archives of Ophthalmology. 2006; 124(1): 12-9. http://archopht.ama-assn.org/cgi/content/abstract/124/1/12

Reference

Title
A Multicenter, Retrospective Pilot Study of Resource Use and Costs Associated with Severity of Disease in Glaucoma
Publication
Archives of Ophthalmology
Publication Date
2006
Authors
Lee, Paul P., John G. Walt, John L. Doyle, Sameer V. Kotak, Stacy J. Evans, Donald L. Budenz, Philip P. Chen, Anne L. Coleman, Robert M. Feldman, Henry D. Jampel, L. Jay Katz, Richard P. Mills, Jonathan S. Myers, Robert J. Noecker, et al
Volume & Issue
Volume 124, Issue 1
Pages
12-9
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • More than 2 million Americans age 50 and older have age-related macular degeneration (AMD)—2,069,403.  
  • The number of Americans age 40 and older with diabetic retinopathy is projected to triple between 2005 and 2050–increasing from 5.5 million to 16 million.  The number of people age…  
  • Of Medicare beneficiaries who were blind from glaucoma, 25.3% were placed in nursing homes, 17% had incident depression, 15.5% experienced a fall and/or an accident, 16.9% suffered an injury, and…  
  • An estimated 6.5% of Americans age 40 and older have age-related macular degeneration (AMD).  
  • Estimated Specific Prevalence Rates for AMD